VTVX HOLDINGS I LLC;TRANSTECH PHARMA LLC;VTV THERAPEUTICS LLC
发明人:
申请号：
IL21482211
公开号：
IL214822A
申请日:
2011.08.25
申请国别(地区):
IL
年份:
2016
代理人:
摘要：
The present invention is directed to substituted azoanthracene derivatives or pharmaceutically acceptable salts thereof that modulate the human GLP-1 receptor and that may be useful in the treatment of diseases, disorders, or conditions in which modulation of the human GLP-1 receptor is beneficial, such as diabetes mellitus type 2. The invention is also directed to pharmaceutical compositions comprising these compounds and to the use of these compounds and compositions in the treatment of such diseases, disorders, or conditions in which modulation of the human GLP-1 receptor is beneficial.
